Literature DB >> 1351500

Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.

R Gazzinelli1, Y Xu, S Hieny, A Cheever, A Sher.   

Abstract

C57BL/6 mice chronically infected with an avirulent strain (ME-49) of Toxoplasma gondii were used to study the mechanisms by which T lymphocytes and IFN-gamma prevent reactivation of latent infection. Infected animals were treated with mAb, either anti-CD8, anti-CD4, anti-CD4 plus anti-CD8, anti-IFN-gamma, or anti-CD4 plus anti-IFN-gamma and the mice followed for survival, histopathology, cyst numbers, and spleen cell cytokine responses. In agreement with previously published findings, treatment with anti-IFN-gamma antibodies fully reactivated the asymptomatic infection, inducing massive necrotic areas in the brain with the appearance of free tachyzoites and death of all animals within 2 wk. Mice treated with the combination of anti-CD4 plus anti-CD8 antibodies showed augmented pathology and mortality nearly identical to the anti-IFN-gamma- treated animals. In contrast, treatment with anti-CD4 or anti-CD8 mAb alone failed to result in significantly enhanced brain pathology or mortality. In additional experiments, full reactivation of infection was observed in mice treated with anti-CD4 plus anti-IFN-gamma indicating that CD4+ lymphocytes are not required for the pathology resulting from IFN-gamma neutralization. Cytokine measurements on parasite Ag-stimulated spleen cells from mAb-treated mice indicated that both CD4+ and CD8+ cells produce IFN-gamma whereas only CD4+ cells contribute to parasite Ag-induced IL-2 synthesis. Together, these results suggest that CD4+ and CD8+ lymphocytes act additively or synergistically to prevent reactivation of chronic T. gondii infection probably through the production of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351500

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  231 in total

1.  CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells.

Authors:  Lori Casciotti; Kenneth H Ely; Martha E Williams; Imtiaz A Khan
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Immunotherapy of a murine T cell lymphoma localized to the brain.

Authors:  V K Ghant; N S Hiramoto; G Y Gillespie; D K Gauthier; R N Hiramoto
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

Review 3.  Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma.

Authors:  Christopher A Hunter; Linda A Lieberman; Nicola Mason; Marion Pepper; Sarah L Sague; Cristina Tato; Valerie Zediak
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 4.  An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.

Authors:  Eric Y Denkers; David J Bzik; Barbara A Fox; Barbara A Butcher
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

5.  PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

6.  CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis.

Authors:  Kazumi Norose; Akitoshi Kikumura; Andrew D Luster; Christopher A Hunter; Tajie H Harris
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

Review 7.  Trafficking of immune cells in the central nervous system.

Authors:  Emma H Wilson; Wolfgang Weninger; Christopher A Hunter
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

8.  CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection.

Authors:  Corinne C Ploix; Shahani Noor; Janelle Crane; Kokoechat Masek; Whitney Carter; David D Lo; Emma H Wilson; Monica J Carson
Journal:  Brain Behav Immun       Date:  2010-09-22       Impact factor: 7.217

9.  Chronic Toxoplasma gondii Infection Induces Anti-N-Methyl-d-Aspartate Receptor Autoantibodies and Associated Behavioral Changes and Neuropathology.

Authors:  Ye Li; Raphael P Viscidi; Geetha Kannan; Ross McFarland; Mikhail V Pletnikov; Emily G Severance; Robert H Yolken; Jianchun Xiao
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

10.  BALB/c mice resistant to Toxoplasma gondii infection proved to be highly susceptible when previously infected with Myocoptes musculinus fur mites.

Authors:  Aurea Welter; José Roberto Mineo; Deise Aparecida de Oliveira Silva; Elaine Vicente Lourenço; Eloísa Amália Vieira Ferro; Maria Cristina Roque-Barreira; Neide Maria da Silva
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.